Sophie Lehn

Phone+46462226443
Emailsophie.lehnmed.luse

If you made any changes in Pure these will be visible here soon.

UKÄ subject classification

Cancer and Oncology

Fingerprint

Dive into the research topics where Sophie Lehn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

11 Article
1 Published meeting abstract
1 Doctoral Thesis (compilation)

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
Roswall, P., Bocci, M., Bartoschek, M., Li, H., Kristiansen, G., Jansson, S., Lehn, S., Sjölund, J., Reid, S., Larsson, C., Eriksson, P., Anderberg, C., Cortez, E., Saal, L. H., Orsmark-Pietras, C., Cordero, E., Haller, B. K., Häkkinen, J., Burvenich, I. J. G., Lim, E., & 7 othersOrimo, A., Höglund, M., Rydén, L., Moch, H., Scott, A. M., Eriksson, U. & Pietras, K., 2018 Mar 12, In: Nature Medicine. 24, p. 463–473
Research output: Contribution to journal › Article › peer-review
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.
Michaut, M., Chin, S-F., Majewski, I., Severson, T. M., Bismeijer, T., de Koning, L., Peeters, J. K., Schouten, P. C., Rueda, O. M., Bosma, A. J., Tarrant, F., Fan, Y., He, B., Xue, Z., Mittempergher, L., Kluin, R. J. C., Heijmans, J., Snel, M., Pereira, B., Schlicker, A., & 26 othersProvenzano, E., Ali, H. R., Gaber, A., O'Hurley, G., Lehn, S., Muris, J. J. F., Wesseling, J., Kay, E., Sammut, S. J., Bardwell, H. A., Barbet, A. S., Bard, F., Lecerf, C., O'Connor, D. P., Vis, D. J., Benes, C. H., McDermott, U., Garnett, M. J., Simon, I. M., Jirström, K., Dubois, T., Linn, S. C., Gallagher, W. M., Wessels, L. F. A., Caldas, C. & Bernards, R., 2016, In: Scientific Reports. 6, 18517.
Research output: Contribution to journal › Article › peer-review

Open Access
Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
Welinder, C., Jirström, K., Lehn, S., Nodin, B., Marko-Varga, G., Blixt, O., Danielsson, L. & Jansson, B., 2016, In: Heliyon. 2, 8, e00143.
Research output: Contribution to journal › Article › peer-review

Open Access
Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
Larsson, A. H., Lehn, S., Wangefjord, S., Karnevi, E., Kuteeva, E., Sundström, M., Nodin, B., Uhlén, M., Eberhard, J., Birgisson, H. & Jirström, K., 2016 May 10, In: Journal of Translational Medicine. 14, 1, 128.
Research output: Contribution to journal › Article › peer-review

Open Access
Therapeutic Targeting of Nuclear Gamma-Tubulin in RB1-negative Tumors.
Lindström, L., Villoutreix, B. O., Lehn, S., Hellsten, R., Nilsson, E., Crneta, E., Olsson, R. & Alvarado-Kristensson, M., 2015, In: Molecular Cancer Research. 13, 7, p. 1073-1082
Research output: Contribution to journal › Article › peer-review

Sophie Lehn

Personal profile

UKÄ subject classification

Fingerprint

Research output

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer

Therapeutic Targeting of Nuclear Gamma-Tubulin in RB1-negative Tumors.